Schrodinger, Inc. (NASDAQ:SDGR – Get Free Report) was up 6.1% during mid-day trading on Friday. The stock traded as high as $27.22 and last traded at $27.9870. 145,014 shares were traded during trading, a decline of 90% from the average daily volume of 1,522,040 shares. The stock had previously closed at $26.39.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on SDGR shares. Zacks Research upgraded Schrodinger from a “hold” rating to a “strong-buy” rating in a research report on Monday. Weiss Ratings raised Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 27th. UBS Group assumed coverage on shares of Schrodinger in a report on Friday, August 14th. They issued a “neutral” rating and a $19.00 target price on the stock. Finally, Wall Street Zen raised shares of Schrodinger from a “strong sell” rating to a “hold” rating in a research note on Saturday, August 8th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Schrodinger has a consensus rating of “Moderate Buy” and an average price target of $20.80.
Get Our Latest Stock Analysis on Schrodinger
Schrodinger Trading Up 4.0%
Schrodinger (NASDAQ:SDGR – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.49. The business had revenue of $58.89 million during the quarter, compared to analysts’ expectations of $47.19 million. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The business’s revenue was up 7.5% on a year-over-year basis. During the same quarter last year, the business posted ($0.65) EPS. As a group, research analysts predict that Schrodinger, Inc. will post -1.5 EPS for the current year.
Insider Activity at Schrodinger
In related news, insider Karen Akinsanya sold 31,599 shares of the firm’s stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $29.37, for a total value of $928,062.63. Following the completion of the sale, the insider owned 69,956 shares of the company’s stock, valued at $2,054,607.72. This trade represents a 31.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.10% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. GAMMA Investing LLC raised its holdings in Schrodinger by 5.7% in the 3rd quarter. GAMMA Investing LLC now owns 14,353 shares of the company’s stock worth $446,000 after purchasing an additional 772 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new position in shares of Schrodinger during the second quarter valued at about $102,000. Squarepoint Ops LLC increased its position in shares of Schrodinger by 290.4% during the second quarter. Squarepoint Ops LLC now owns 209,123 shares of the company’s stock valued at $3,398,000 after buying an additional 155,556 shares during the period. Allworth Financial LP raised its stake in Schrodinger by 252.3% in the second quarter. Allworth Financial LP now owns 5,270 shares of the company’s stock worth $86,000 after buying an additional 3,774 shares in the last quarter. Finally, Corient Private Wealth LP bought a new position in Schrodinger in the second quarter worth about $303,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Schrodinger Company Profile
Schrödinger, Inc is a technology company that develops computational software for pharmaceutical and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists design and optimize molecules, evaluate potential drug candidates and investigate material properties.
The company’s software offerings include molecular modeling, simulation, predictive modeling and collaborative research tools, such as Maestro, Desmond, Jaguar, FEP+ and LiveDesign.
Recommended Stories
- Five stocks we like better than Schrodinger
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
- Microsoft Is Almost Back to $555—Now the Hard Part Begins
- Marvell Says Connecting AI Chips Could Be a $37 Billion Business—These 2 Stocks Rallied Too
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
